What is it about?
Delays in trastuzumab dosing are not uncommon, leading to concerns of subtherapeutic serum level and the need for a reloading dose.
Featured Image
Why is it important?
Reloading is probably only needed after a delay of more than six weeks and is likely necessary if longer than eight weeks. This is significantly less demanding than that recommended by the manufacturer.
Read the Original
This page is a summary of: Trastuzumab therapy in breast cancer: To reload or not to reload?, Journal of Oncology Pharmacy Practice, October 2013, SAGE Publications,
DOI: 10.1177/1078155213506478.
You can read the full text:
Contributors
The following have contributed to this page